Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 111 results for "zydus group"

Zydus Cadila launches most affordable gliptin for diabetics in...

Indian drugmaker Zydus Cadila (BSE: 532321) has launched its Tenglyn (teneligliptin 20mg) tablets, which belongs to a new class of oral anti-diabetic agents dubbed gliptins. With an aim to make this important therapy affordable and accessible to ... Pharma Letter, 1 week ago
Drug launch to keep Cadila Health in focus Hindu Business Line, 1 week ago
Zydus launches Tenglyn tablets in Indian market Economic Times, 1 week ago

Zydus gets USFDA nod for clinical trials of Sarolitazar

NEW DELHI: Zydus Cadila has received US health regulator's nod to initiate phase II clinical trials of Sarolitazar, its new drug for treating high fat levels in body due to diabetes, obesity, and sedentary habits. "United States Food and Drug ...
 Economic Times1 week ago Zydus gets FDA nod for clinical trials of Sarolitazar  Daily Excelsior.com1 week ago
Business Standard India

Zydus Cadila profit up 41% to Rs 391 crore

Operating revenue grew 17% to Rs 2460 crore and sales in US market grew 25% to Rs 1004 crore BS Reporter | Mumbai October 22, 2015 Last Updated at 23:13 IST Drug maker Zydus Cadila posted a 41 per cent growth in consolidated net profit at Rs 391 ...
 Business Standard India1 month ago Cadila Healthcare net profit surges 40% to Rs 391 crore in Q2  DNA India1 month ago
Best Media Info

Nilay Moonje joins DDB Mudra West as Group Creative Director

Moonje joins DDB Mudra West from Ogilvy & Mather, where he was a Creative Director BestMediaInfo Bureau | Mumbai | September 29, 2015 Nilay Moonje DDB Mudra Group has recently announced the appointment of Nilay Moonje as Group Creative ...
 Best Media Info2 months ago

Zydus announces clinical trials of Saroglitazar in patients with Severe Hypertriglyceridemia in USA

Details Category: Small Molecules Published on Wednesday, 18 November 2015 09:24 Hits: 44 AHMEDABAD, India I November 18, 2015 I Zydus today announced that USFDA has endorsed company's plan to initiate a Phase 2 clinical trial of Saroglitazar ...
 PipelineReview1 week ago

Global Biopharmaceuticals Industry

LONDON, Nov. 26, 2015 /PRNewswire/ This report analyzes the worldwide markets for Biopharmaceuticals in US$ Million by the following Segments: Recombinant Protein, Monoclonal Antibodies (mAbs), Insulin, and Vaccines. The report provides separate ...
 Pharmacy Choice2 days ago

Cholesterol-lowering Drugs Market Forecast 2015-2025

Opportunities in PCSK9 Inhibitors, CETP Inhibitors, MTTP Inhibitors, ApoB Inhibitors and PPAR Agonists What can be expected from the cholesterol-lowering drugs market? Which areas are going to grow at the fastest rates? This visiongain report ...
 Fat Pitch Financials4 days ago

Health ministry plans to revamp regulatory rules for biosimilar drugs

MUMBAI: The health ministry plans to revamp guidelines for approving biosimilar drugs to make the regulatory pathway more robust and sync it with the rapidly evolving global landscape. The guidelines were released three years ago. Biosimilars are ...
 Economic Times1 week ago

Biosimilar market is projected to be worth USD 32 billion worldwide by 2025 According to 'Global Biosimilars Market, 2015-2025'

Dublin, Nov. 12, 2015 (GLOBE NEWSWIRE) -- Research and Markets ( ) has announced the addition of the "Global Biosimilars Market, 2015 - 2025" report to their offering. Overall, with the ...
 Franklin Credit Management Corporation2 weeks ago Contract Manufacturing in Pharmaceutical Industry, 2015-2025 - North America and Europe are the predominant regions where majority of the production facilities of CMOs are located  Tutorial Finder2 weeks ago Biopharmaceutical Contract Manufacturing Market to 2025 - Market To Grow At An Annual Rate Of 8.3%, Driven By The Rapidly Expanding Biopharmaceutical Market And Technological Advancements  Individual.com2 weeks ago Global Biosimilars Market Report, 2015-2025 - The biosimilar market is projected to be worth USD 32 billion worldwide by 2025  Ulitzer3 weeks ago


Many Indian drug companies have been facing warnings and have been issued bans by the United States Food and Drug Administration (US FDA) in recent years. They are looking to protect exports to US pharmaceuticals market. ...
 Pharmacy Choice1 month ago Drugmakers plan to get together to discuss how to get out of FDA warnings and bans  Economic Times1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - zydus group
Get updated on latest news & your favorite topics right in your inbox!
More     Less